Skip to Main Content

Paper Details

A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation.
British Journal of Haematology
8
2015

Datasets

Release 1.2